APGE vs CPB · $2.34B cap vs P/E 12, rev $10.25B
Apogee Therapeutics, Inc. Common Stock (APGE) versus Campbell’s Co (CPB) — a side-by-side from cached financials, not a winner call.
Apogee Therapeutics, Inc. Common Stock (APGE) is a biotechnology company listed on US.
Campbell’s Co (CPB) is a packaged foods company listed on US.
APGE does not have a complete income-statement cache yet.
Latest reported CPB revenue for 2025-08-03 was $10.25B. Net income was $602.0M. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
APGE currently screens at market cap $2.34B. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
Not investment advice. Open the APGE and CPB stock pages for the full models.
Not investment advice.